First report of the global SYMPLICITY registry on the effect of renal artery denervation in patients with uncontrolled hypertension

Hypertension

Volumn 65, Issue 4, 2015, Pages 766-774

  Böhm, Michael ^a   Mahfoud, Felix ^a   Ukena, Christian ^a   Hoppe, Uta C ^b   Narkiewicz, Krzysztof ^c   Negoita, Manuela ^d   Ruilope, Luis ^e   Schlaich, Markus P ^f   Schmieder, Roland E ^g   Whitbourn, Robert ^h   Williams, Bryan ⁱ   Zeymer, Uwe ^j   Zirlik, Andreas ^k   Mancia, Giuseppe ^l  

^a SAARLAND UNIVERSITY   (Germany)

^b UNIVERSITY OF SALZBURG   (Austria)

^c MEDICAL UNIVERSITY OF GDANSK   (Poland)

^d MEDTRONIC INC   (United States)

^e HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

^f UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^g UNIVERSITY HOSPITAL ERLANGEN   (Germany)

^h ST VINCENT S HOSPITAL   (Australia)

ⁱ UNIVERSITY COLLEGE LONDON   (United Kingdom)

^j KLINIKUM LUDWIGSHAFEN   (Germany)

^k UNIVERSITY HEART CENTER FREIBURG BAD KROZINGEN   (Germany)

^l UNIVERSITY OF MILANO BICOCCA   (Italy)

more..

Author keywords

denervation; hypertension; sympathetic nervous system

Indexed keywords

ADRENERGIC RECEPTOR BLOCKING AGENT; ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ANGIOTENSIN RECEPTOR; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; GLUCOSE; HEMOGLOBIN A1C; RENIN INHIBITOR; SPIRONOLACTONE; VASODILATOR AGENT;

ADULT; ANTIHYPERTENSIVE THERAPY; ARTICLE; ATRIAL FIBRILLATION; BLOOD PRESSURE MONITORING; CEREBROVASCULAR ACCIDENT; CLINICAL EFFECTIVENESS; COHORT ANALYSIS; CREATININE BLOOD LEVEL; DIABETES MELLITUS; END STAGE RENAL DISEASE; FAINTNESS; FEMALE; FOLLOW UP; GLUCOSE BLOOD LEVEL; HEART EJECTION FRACTION; HEART INFARCTION; HOSPITALIZATION; HUMAN; HYPERTENSION; HYPERTENSIVE CRISIS; KIDNEY ARTERY STENOSIS; KIDNEY DENERVATION; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; MASKED HYPERTENSION; MIDDLE AGED; MULTICENTER STUDY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROSPECTIVE STUDY; SUICIDE ATTEMPT; SYSTOLIC BLOOD PRESSURE; VASCULAR DISEASE; ADRENERGIC SYSTEM; BLOOD PRESSURE; CLINICAL TRIAL; CONTROLLED STUDY; INNERVATION; KIDNEY ARTERY; PATHOPHYSIOLOGY; PHYSIOLOGY; PROCEDURES; RANDOMIZED CONTROLLED TRIAL; REGISTER; SYMPATHECTOMY; TIME; TREATMENT OUTCOME;

BLOOD PRESSURE; BLOOD PRESSURE MONITORING, AMBULATORY; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; REGISTRIES; RENAL ARTERY; SYMPATHECTOMY; SYMPATHETIC NERVOUS SYSTEM; TIME FACTORS; TREATMENT OUTCOME;

EID: 84929130721     PISSN: 0194911X     EISSN: 15244563     Source Type: Journal    
DOI: 10.1161/HYPERTENSIONAHA.114.05010     Document Type: Article

References (37)

1. Staessen JA, Kuznetsova T, Stolarz K. Hypertension prevalence and stroke mortality across populations. JAMA. 2003; 289: 2420-2422. doi: 10.1001/jama.289.18.2420
2. Mancia G, Fagard R, Narkiewicz K, et al. 2013 ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J. 2013; 34: 2159-2219. doi: 10.1093/eurheartj/eht151
3. Sobotka PA, Mahfoud F, Schlaich MP, Hoppe UC, Böhm M, Krum H. Sympatho-renal axis in chronic disease. Clin Res Cardiol. 2011; 100: 1049-1057. doi: 10.1007/s00392-011-0335-y
4. Hering D, Esler MD, Krum H, Mahfoud F, Böhm M, Sobotka PA, Schlaich MP. Recent advances in the treatment of hypertension. Expert Rev Cardiovasc Ther. 2011; 9: 729-744. doi: 10.1586/erc.11.71
5. Mancia G, Grassi G. The autonomic nervous system and hypertension. Circ Res. 2014; 114: 1804-1814. doi: 10.1161/CIRCRESAHA.114.302524
6. Krum H, Sobotka P, Mahfoud F, Böhm M, Esler M, Schlaich M. Devicebased antihypertensive therapy: therapeutic modulation of the autonomic nervous system. Circulation. 2011; 123: 209-215. doi: 10.1161/CIRCULATIONAHA.110.971580
7. Krum H, Schlaich M, Whitbourn R, Sobotka PA, Sadowski J, Bartus K, Kapelak B, Walton A, Sievert H, Thambar S, Abraham WT, Esler M. Catheter-based renal sympathetic denervation for resistant hypertension: a multicentre safety and proof-of-principle cohort study. Lancet. 2009; 373: 1275-1281. doi: 10.1016/S0140-6736(09)60566-3
8. Esler MD, Krum H, Sobotka PA, Schlaich MP, Schmieder RE, Bohm M. Renal sympathetic denervation in patients with treatment-resistant hypertension (The Symplicity HTN-2 Trial): a randomised controlled trial. Lancet. 2010; 376: 1903-1909
9. Krum H, Schlaich MP, Sobotka PA, Böhm M, Mahfoud F, Rocha-Singh K, Katholi R, Esler MD. Percutaneous renal denervation in patients with treatment-resistant hypertension: final 3-year report of the Symplicity HTN-1 study. Lancet. 2014; 383: 622-629. doi: 10.1016/S0140-6736(13)62192-3
10. Esler MD, Böhm M, Sievert H, Rump CL, Schmieder RE, Krum H, Mahfoud F, Schlaich MP. Catheter-based renal denervation for treatment of patients with treatment-resistant hypertension: 36 month results from the SYMPLICITY HTN-2 randomized clinical trial. Eur Heart J. 2014; 35: 1752-1759. doi: 10.1093/eurheartj/ehu209
11. Bhatt DL, Kandzari DE, O'Neill WW, D'Agostino R, Flack JM, Katzen BT, Leon MB, Liu M, Mauri L, Negoita M, Cohen SA, Oparil S, Rocha-Singh K, Townsend RR, Bakris GL; SYMPLICITY HTN-3 Investigators. A controlled trial of renal denervation for resistant hypertension. N Engl J Med. 2014; 370: 1393-1401. doi: 10.1056/NEJMoa1402670
12. Esler MD, Krum H, Schlaich M, Schmieder RE, Böhm M, Sobotka PA; Symplicity HTN-2 Investigators. Renal sympathetic denervation for treatment of drug-resistant hypertension: one-year results from the Symplicity HTN-2 randomized, controlled trial. Circulation. 2012; 126: 2976-2982. doi: 10.1161/CIRCULATIONAHA.112.130880
13. Hering D, Lambert EA, Marusic P, Ika-Sari C, Walton AS, Krum H, Sobotka PA, Mahfoud F, Böhm M, Lambert GW, Esler MD, Schlaich MP. Renal nerve ablation reduces augmentation index in patients with resistant hypertension. J Hypertens. 2013; 31: 1893-1900. doi: 10.1097/HJH.0b013e3283622e58
14. Brandt MC, Mahfoud F, Reda S, Schirmer SH, Erdmann E, Böhm M, Hoppe UC. Renal sympathetic denervation reduces left ventricular hypertrophy and improves cardiac function in patients with resistant hypertension. J Am Coll Cardiol. 2012; 59: 901-909. doi: 10.1016/j.jacc.2011.11.034
15. Mahfoud F, Urban D, Teller D, et al. Effect of renal denervation on left ventricular mass and function in patients with resistant hypertension: data from a multi-centre cardiovascular magnetic resonance imaging trial. Eur Heart J. 2014; 35: 2224-231b. doi: 10.1093/eurheartj/ehu093
16. Ott C, Mahfoud F, Schmid A, Ditting T, Veelken R, Ewen S, Ukena C, Uder M, Böhm M, Schmieder RE. Improvement of albuminuria after renal denervation. Int J Cardiol. 2014; 173: 311-315. doi: 10.1016/j. ijcard.2014.03.017
17. Mahfoud F, Cremers B, Janker J, et al. Renal hemodynamics and renal function after catheter-based renal sympathetic denervation in patients with resistant hypertension. Hypertension. 2012; 60: 419-424. doi: 10.1161/HYPERTENSIONAHA.112.193870
18. Linz D, Mahfoud F, Schotten U, Ukena C, Neuberger HR, Wirth K, Böhm M. Renal sympathetic denervation suppresses postapneic blood pressure rises and atrial fibrillation in a model for sleep apnea. Hypertension. 2012; 60: 172-178. doi: 10.1161/HYPERTENSIONAHA.112.191965
19. Böhm M, Mahfoud F, Ukena C, et al. Rationale and design of a large registry on renal denervation: the Global SYMPLICITY registry. EuroIntervention. 2013; 9: 484-492. doi: 10.4244/EIJV9I4A78
20. O'Brien E, Parati G, Stergiou G, et al; European Society of Hypertension Working Group on Blood Pressure Monitoring. European Society of Hypertension position paper on ambulatory blood pressure monitoring. J Hypertens. 2013; 31: 1731-1768. doi: 10.1097/HJH.0b013e328363e964
21. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med. 1999; 130: 461-470
22. Ukena C, Mahfoud F, Spies A, Kindermann I, Linz D, Cremers B, Laufs U, Neuberger HR, Böhm M. Effects of renal sympathetic denervation on heart rate and atrioventricular conduction in patients with resistant hypertension. Int J Cardiol. 2013; 167: 2846-2851. doi: 10.1016/j. ijcard.2012.07.027
23. Hering D, Marusic P, Walton AS, Lambert EA, Krum H, Narkiewicz K, Lambert GW, Esler MD, Schlaich MP. Sustained sympathetic and blood pressure reduction 1 year after renal denervation in patients with resistant hypertension. Hypertension. 2014; 64: 118-124. doi: 10.1161/HYPERTENSIONAHA.113.03098
24. Mahfoud F, Schlaich M, Kindermann I, Ukena C, Cremers B, Brandt MC, Hoppe UC, Vonend O, Rump LC, Sobotka PA, Krum H, Esler M, Böhm M. Effect of renal sympathetic denervation on glucose metabolism in patients with resistant hypertension: a pilot study. Circulation. 2011; 123: 1940-1946. doi: 10.1161/CIRCULATIONAHA.110.991869
25. Kandzari DE, Bhatt DL, Brar S, Devireddy CM, Esler M, Fahy M, Flack JM, Katzen BT, Lea J, Lee DP, Leon MB, Ma A, Massaro J, Mauri L, Oparil S. Predictors of blood pressure response in the SYMPLICITY HTN-3 trial. Eur Heart J. 2015; 36: 219-227. doi: 10.1093/eurheartj/ehu441
26. Barnett AG, van der Pols JC, Dobson AJ. Regression to the mean: what it is and how to deal with it. Int J Epidemiol. 2005; 34: 215-220. doi: 10.1093/ije/dyh299
27. Persu A, Jin Y, Azizi M, et al; European Network COordinating research on Renal Denervation (ENCOReD). Blood pressure changes after renal denervation at 10 European expert centers. J Hum Hypertens. 2014; 28: 150-156. doi: 10.1038/jhh.2013.88
28. Warren RE, Marshall T, Padfield PL, Chrubasik S. Variability of office, 24-hour ambulatory, and self-monitored blood pressure measurements. Br J Gen Pract. 2010; 60: 675-680. doi: 10.3399/bjgp10X515403
29. Mancia G, Zanchetti A, Agabiti-Rosei E, Benemio G, De Cesaris R, Fogari R, Pessina A, Porcellati C, Rappelli A, Salvetti A, Trimarco B, Agebiti-Rosei E, Pessino A. Ambulatory blood pressure is superior to clinic blood pressure in predicting treatment-induced regression of left ventricular hypertrophy. SAMPLE Study Group. Study on Ambulatory Monitoring of Blood Pressure and Lisinopril Evaluation. Circulation. 1997; 95: 1464-1470
30. Sega R, Facchetti R, Bombelli M, Cesana G, Corrao G, Grassi G, Mancia G. Prognostic value of ambulatory and home blood pressures compared with office blood pressure in the general population: followup results from the Pressioni Arteriose Monitorate e Loro Associazioni (PAMELA) study. Circulation. 2005; 111: 1777-1783. doi: 10.1161/01. CIR.0000160923.04524.5B
31. Fagard RH, Celis H, Thijs L, Staessen JA, Clement DL, De Buyzere ML, De Bacquer DA. Daytime and nighttime blood pressure as predictors of death and cause-specific cardiovascular events in hypertension. Hypertension. 2008; 51: 55-61. doi: 10.1161/HYPERTENSIONAHA.107.100727
32. Metoki H, Ohkubo T, Kikuya M, Asayama K, Obara T, Hashimoto J, Totsune K, Hoshi H, Satoh H, Imai Y. Prognostic significance for stroke of a morning pressor surge and a nocturnal blood pressure decline: the Ohasama study. Hypertension. 2006; 47: 149-154. doi: 10.1161/01. HYP.0000198541.12640.0f
33. Mahfoud F, Ukena C, Schmieder RE, et al. Ambulatory blood pressure changes after renal sympathetic denervation in patients with resistant hypertension. Circulation. 2013; 128: 132-140. doi: 10.1161/CIRCULATIONAHA.112.000949
34. Mancia G, Parati G. Office compared with ambulatory blood pressure in assessing response to antihypertensive treatment: a meta-analysis. J Hypertens. 2004; 22: 435-445
35. Mancia G, Parati G, Bilo G, et al. Ambulatory blood pressure values in the Ongoing Telmisartan Alone and in Combination with Ramipril Global Endpoint Trial (ONTARGET). Hypertension. 2012; 60: 1400-1406. doi: 10.1161/HYPERTENSIONAHA.112.199562
36. Mancia G, Sega R, Grassi G, Cesana G, Zanchetti A. Defining ambulatory and home blood pressure normality: further considerations based on data from the PAMELA study. J Hypertens. 2001; 19: 995-999
37. Parati G, Pomidossi G, Casadei R, Mancia G. Lack of alerting reactions to intermittent cuff inflations during noninvasive blood pressure monitoring. Hypertension. 1985; 7: 597-601